New York, June 4 (Ians) Adding a novel drug to hormone therapy can help block the return of the most common form of breast cancer by 25 per cent, according to a study.
Researchers found that patients with early hormone-receptor (Hr) positive/HER2 negative breast cancer who took the combination therapy — ribociclib, a targeted therapy drug, and hormone therapy — had substantially longer invasive disease-free survival compared to those who were treated with the hormone therapy alone.
This was regardless of whether the cancer has spread to the lymph nodes, said the team from University of California, Los Angeles.
The addition of the targeted therapy reduced the risk of recurrence by 25 per cent, they noted while presenting the study at the American Society of Clinical Oncology Annual Meeting.
“The findings show this combination is a treatment of choice for patients with stage 2 or stage 3 Hr positive/HER2 negative breast cancer,” said Dr Dennis Slamon,...
Researchers found that patients with early hormone-receptor (Hr) positive/HER2 negative breast cancer who took the combination therapy — ribociclib, a targeted therapy drug, and hormone therapy — had substantially longer invasive disease-free survival compared to those who were treated with the hormone therapy alone.
This was regardless of whether the cancer has spread to the lymph nodes, said the team from University of California, Los Angeles.
The addition of the targeted therapy reduced the risk of recurrence by 25 per cent, they noted while presenting the study at the American Society of Clinical Oncology Annual Meeting.
“The findings show this combination is a treatment of choice for patients with stage 2 or stage 3 Hr positive/HER2 negative breast cancer,” said Dr Dennis Slamon,...
- 6/4/2023
- by Agency News Desk
- GlamSham
On Wednesday, June 3, 2015 at The Four Seasons Hotel Beverly Hills Courteney Cox, Kelly Meyer, Rashida Jones, Elaine Irwin, Erin Foster, Lorraine Bracco and more were hosted by Halle Berry, actress and Revlon Brand Ambassador, Lorenzo Delpani, CEO of Revlon, Inc., Ronald Perelman, Chairman and Chief Executive Officer of MacAndrews & Forbes Incorporated for the Revlon Love Is On Luncheon honoring the achievements of Dr. Dennis Slamon at the Four Seasons Hotel Beverly Hills.According to StandUp2Cancer.org:Dennis Slamon is one of the miracle workers at the center of Stand Up To Cancer. His role in the development of Herceptin is […]...
- 6/5/2015
- by April Neale
- Monsters and Critics
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.